Moderna Inc
(NASDAQ:MRNA)
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
top performing MRNA trades
-19.60%
-30.40%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Moderna trades made by congress members.
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Mar 07, 2024 | Feb 01, 2024 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Oct 15, 2023 | Sep 15, 2023 | House |
Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Sale | Aug 13, 2023 | Jul 12, 2023 | House |
Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Purchase | May 19, 2023 | Apr 10, 2023 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Apr 20, 2023 | Mar 31, 2023 | House |
Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Sale | Apr 17, 2023 | Mar 06, 2023 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Apr 17, 2022 | Mar 16, 2022 | House |